Cargando…
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center
BACKGROUND: Cytomegalovirus (CMV) is a common opportunistic infection in patients after liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however, valganciclovir commonly causes dose‐dependent hematologic toxicities. Use of a low‐dose valganciclovir (450 mg) has been used t...
Autores principales: | Viehl, Emily, Lichvar, Alicia, Chan, Christine, Choi, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541473/ https://www.ncbi.nlm.nih.gov/pubmed/35604549 http://dx.doi.org/10.1111/tid.13867 |
Ejemplares similares
-
Anakinra/steroids: Cytomegalovirus viremia: case report
Publicado: (2022) -
Cytomegalovirus Viremia in Renal Transplant Recipients After Influenza Vaccination
por: Khatri, Akshay M, et al.
Publicado: (2020) -
Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2020) -
Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion
por: Ribeiro, Rafaela V.P., et al.
Publicado: (2023) -
Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
por: van Duin, David, et al.
Publicado: (2011)